bluebird bio Announces September Investor Events

On September 5, 2023 bluebird bio, Inc. (Nasdaq: BLUE) reported that members of the management team will participate in fireside chats at the following upcoming investor conferences (Press release, bluebird bio, SEP 5, 2023, View Source [SID1234634881]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Morgan Stanley 21st Annual Global Healthcare Conference, Monday, September 11, at 12:15 p.m. ET at the Sheraton, New York, NY
Baird 2023 Global Healthcare Conference, Tuesday, September 12, at 2:00 p.m. ET at the Intercontinental New York Barclay, New York, NY
To access the live webcast of bluebird bio’s fireside chats, please visit the "Events & Presentations" page within the Investors & Media section of the bluebird bio website at View Source Replays of the webcasts will be available on the bluebird bio website for 90 days following the events.

Black Diamond Therapeutics to Participate in Upcoming Investor Conferences

On September 5, 2023 Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a clinical-stage precision oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with genetically defined cancers, reported that company management will participate in three upcoming investor conferences (Press release, Black Diamond Therapeutics, SEP 5, 2023, View Source [SID1234634880]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The 2023 Wells Fargo Healthcare Conference on Wednesday, September 6, 2023, in Boston, MA.
The Morgan Stanley 21st Annual Global Healthcare Conference on Monday, September 11, 2023. Black Diamond President and Chief Executive Officer, David M. Epstein, Ph.D. will participate in a fireside chat at 3:35 p.m. ET in New York, NY.

The H.C. Wainwright 25th Annual Global Investment Conference on Tuesday, September 12, 2023. Black Diamond Chief Business Officer and Chief Financial Officer, Fang Ni, Pharm.D. will present at 11:00 a.m. ET in New York, NY.

A live webcast of the Morgan Stanley fireside chat and H.C. Wainwright presentation can be accessed by visiting the investors relations section of the Company’s website at: www.blackdiamondtherapeutics.com. A replay of the webcast will also be available and archived for 90 days following the event.

BioMarin to Participate in Three Upcoming Investor Conferences

On September 5, 2023 BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) reported that company management will present at three upcoming investor conferences in September (Press release, BioMarin, SEP 5, 2023, View Source [SID1234634879]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

An audio webcast of the presentations will be available live. You can access the webcasts at: View Source An archived version of the remarks will also be available through the Company’s website for a limited time following the conference.

Biodesix to Participate in Two Upcoming Investor Conferences in September

On September 5, 2023 Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, reported Scott Hutton, Chief Executive Officer of Biodesix, will participate in two upcoming investor conferences (Press release, Biodesix, SEP 5, 2023, View Source [SID1234634878]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Morgan Stanley 21st Annual Global Healthcare Conference
Fireside Chat and 1×1 Meetings
Fireside Date: Tuesday, September 12, 2023
Fireside Time: 12:15 PM ET
Location: Sheraton Hotel, New York, NY

H.C. Wainwright 25th Annual Global Investment Conference
1×1 meetings only
Date: September 13, 2023
Location: Lotte New York Palace Hotel, New York, NY

The fireside chat at the Morgan Stanley 21st Annual Global Healthcare Conference will be webcast live and available for replay under "News & Events" in the Investors section of the Company’s website at www.biodesix.com.

Bicycle Therapeutics to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference

On September 5, 2023 Bicycle Therapeutics (NASDAQ: BCYC), a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle) technology, reported that management will participate in a fireside chat at the Morgan Stanley 21st Annual Global Healthcare Conference in New York on September 12, 2023, at 10:10 a.m. ET (Press release, Bicycle Therapeutics, SEP 5, 2023, View Source [SID1234634877]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

A live webcast of the fireside chat will be accessible in the Investors & Media section of Bicycle Therapeutic’s website at www.bicycletherapeutics.com. An archived replay of the webcast will be available following the event.